Fingerprint
Dive into the research topics of 'A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically